ATNM vs ZBH · rev $35.0M vs P/E 23, rev $8.23B
Actinium Pharmaceuticals Inc (ATNM) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Actinium Pharmaceuticals Inc (ATNM) is a biotechnology company listed on US.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported ATNM revenue for 2026-06-30 was $35.0M. Net income was $22.4M. Revenue was up 38788.9% from 2025-09-30 to 2026-06-30. ATNM currently screens at market cap $33.9M.
Latest reported ZBH revenue for 2025-12-31 was $8.23B. Net income was $705.1M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
ATNM currently screens at market cap $33.9M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the ATNM and ZBH stock pages for the full models.
Not investment advice.